Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


IGF-I activates the mouse type IIb myosin heavy chain gene.

Shanely RA, Zwetsloot KA, Childs TE, Lees SJ, Tsika RW, Booth FW.

Am J Physiol Cell Physiol. 2009 Oct;297(4):C1019-27. doi: 10.1152/ajpcell.00169.2009. Epub 2009 Aug 5.


Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.

Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM.

J Biol Chem. 2005 Apr 1;280(13):13019-28. Epub 2005 Jan 24.


Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.

Verhees KJ, Schols AM, Kelders MC, Op den Kamp CM, van der Velden JL, Langen RC.

Am J Physiol Cell Physiol. 2011 Nov;301(5):C995-C1007. doi: 10.1152/ajpcell.00520.2010. Epub 2011 Aug 10.


Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.

Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J.

Oncogene. 2001 Jan 11;20(2):252-9.


Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.

Seimi SK, Seinosuke K, Tsuyoshi S, Tomomi U, Tetsuaki H, Miki K, Ryuji T, Kenji I, Mitsuhiro Y.

Circ J. 2004 Mar;68(3):247-53.


Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.

van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM.

Am J Physiol Cell Physiol. 2006 Feb;290(2):C453-62. Epub 2005 Sep 14.


Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.

Vangamudi B, Zhu S, Soutto M, Belkhiri A, El-Rifai W.

Mol Cancer. 2011 Mar 29;10:32. doi: 10.1186/1476-4598-10-32.


Nuclear factor-κB modulates osteogenesis of periodontal ligament stem cells through competition with β-catenin signaling in inflammatory microenvironments.

Chen X, Hu C, Wang G, Li L, Kong X, Ding Y, Jin Y.

Cell Death Dis. 2013 Feb 28;4:e510. doi: 10.1038/cddis.2013.14.


Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells.

Cui H, Meng Y, Bulleit RF.

Brain Res Dev Brain Res. 1998 Dec 7;111(2):177-88.


Glycogen synthase kinase-3beta regulates DeltaNp63 gene transcription through the beta-catenin signaling pathway.

Chu WK, Dai PM, Li HL, Chen JK.

J Cell Biochem. 2008 Oct 1;105(2):447-53. doi: 10.1002/jcb.21839.


Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.

Fang CH, Li BG, James JH, King JK, Evenson AR, Warden GD, Hasselgren PO.

Endocrinology. 2005 Jul;146(7):3141-9. Epub 2005 Mar 31.


Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.

Du Q, Park KS, Guo Z, He P, Nagashima M, Shao L, Sahai R, Geller DA, Hussain SP.

Cancer Res. 2006 Jul 15;66(14):7024-31.


GSK-3beta negatively regulates skeletal myotube hypertrophy.

Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C545-51.


Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β.

Pansters NA, van der Velden JL, Kelders MC, Laeremans H, Schols AM, Langen RC.

Cell Mol Life Sci. 2011 Feb;68(3):523-35. doi: 10.1007/s00018-010-0467-7. Epub 2010 Aug 8.


Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop.

Jamieson C, Sharma M, Henderson BR.

Traffic. 2011 Aug;12(8):983-99. doi: 10.1111/j.1600-0854.2011.01207.x. Epub 2011 May 13.


Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.

van der Velden JL, Langen RC, Kelders MC, Willems J, Wouters EF, Janssen-Heininger YM, Schols AM.

Am J Physiol Cell Physiol. 2007 May;292(5):C1636-44. Epub 2006 Dec 13.


Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.

Quinn LS, Anderson BG, Plymate SR.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1538-51. Epub 2007 Oct 16.

Supplemental Content

Support Center